Back to top
more

Acadia Healthcare (ACHC)

(Delayed Data from NSDQ)

$67.34 USD

67.34
1,581,736

+2.27 (3.49%)

Updated May 30, 2024 04:00 PM ET

After-Market: $67.40 +0.06 (0.09%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.08%
2Buy17.91%
3Hold9.44%
4Sell5.10%
5Strong Sell2.55%
S&P50011.04%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

C Value F Growth F Momentum F VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 12% (29 out of 250)

Industry: Medical - Hospital

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Zacks News

Why This 1 Value Stock Could Be a Great Addition to Your Portfolio

by Zacks Equity Research

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Why Is Acadia Healthcare (ACHC) Down 4.5% Since Last Earnings Report?

by Zacks Equity Research

Acadia Healthcare (ACHC) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Why Acadia Healthcare (ACHC) is a Top Value Stock for the Long-Term

by Zacks Equity Research

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Why Acadia Healthcare (ACHC) Dips 1.6% Despite Q1 Earnings Beat

by Zacks Equity Research

Acadia Healthcare (ACHC) aims to add around 300 beds to its existing facilities in 2022.

What Awaits Meridian Bioscience (VIVO) This Earnings Season?

by Zacks Equity Research

Meridian Bioscience's (VIVO) fiscal second-quarter results are likely to reflect continued strength across both its segments.

Has Acadia Healthcare (ACHC) Outpaced Other Medical Stocks This Year?

by Zacks Equity Research

Here is how Acadia Healthcare (ACHC) and Ono Pharmaceutical Co. (OPHLF) have performed compared to their sector so far this year.

Mednax (MD) Q1 Earnings and Revenues Surpass Estimates

by Zacks Equity Research

Mednax (MD) delivered earnings and revenue surprises of 22.22% and 1.75%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

Community Health Systems (CYH) Surpasses Q1 Earnings Estimates

by Zacks Equity Research

Community Health Systems (CYH) delivered earnings and revenue surprises of 7.69% and 1.63%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

Acadia Healthcare (ACHC) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

by Zacks Equity Research

Acadia Healthcare (ACHC) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Universal Health (UHS) Q1 Earnings Miss Mark, Tumble Y/Y

by Zacks Equity Research

Universal Health's (UHS) Q1 results reflect a steep expense level and lower admissions in its Behavioral Health Care Services segment, partially offset by revenue recognition.

    Tenet Healthcare (THC) Q1 Earnings Beat Mark, Surge Y/Y

    by Zacks Equity Research

    Tenet Healthcare (THC) Q1 earnings gain from a healthy revenue stream, reduced expenses and operational efficiency.

    Anthem (ANTM) Q1 Earnings Beat Estimates, Hikes '22 EPS View

    by Zacks Equity Research

    Anthem's (ANTM) first-quarter results indicate solid top-line growth and strong contribution from each of its businesses, partly offset by higher expenses.

    What to Expect Ahead of HCA Healthcare's (HCA) Q1 Earnings?

    by Zacks Equity Research

    HCA Healthcare's (HCA) Q1 earnings are likely to reflect gain from better admissions and a higher revenue stream.

    UnitedHealth's (UNH) Q1 Earnings Surpass Mark, Improve Y/Y

    by Zacks Equity Research

    UnitedHealth's (UNH) Q1 results reflect gains from both its segments, Optum and UnitedHealthcare, along with higher revenues.

    Why This 1 Value Stock Could Be a Great Addition to Your Portfolio

    by Zacks Equity Research

    Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

    Why Acadia Healthcare (ACHC) is a Top Momentum Stock for the Long-Term

    by Zacks Equity Research

    Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

    Why Is Acadia Healthcare (ACHC) Up 12.2% Since Last Earnings Report?

    by Zacks Equity Research

    Acadia Healthcare (ACHC) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

    Acadia Healthcare (ACHC) Up 10% in 3 Months: More Room to Run?

    by Zacks Equity Research

    Solid demand for behavioral healthcare services, multiple growth-related initiatives and a solid cash balance are driving Acadia Healthcare (ACHC).

    Acadia Healthcare (ACHC) JV Adds Service Line, Ups Bed Capacity

    by Zacks Equity Research

    Acadia Healthcare (ACHC) operated (through a JV) Southcoast Behavioral Health includes a pediatric service line and increases bed capacity to 192.

    Acadia Healthcare (ACHC) Eyes Over 600 Bed Additions in 2022

    by Zacks Equity Research

    Acadia Healthcare (ACHC) has two de novo projects in Chicago and Indio, CA, which are expected to add a total of around 140 beds this year.

    Why Acadia Healthcare (ACHC) Stock Might be a Great Pick

    by Zacks Equity Research

    Acadia Healthcare (ACHC) has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well.

    Acadia Healthcare (ACHC) is a Top-Ranked Momentum Stock: Should You Buy?

    by Zacks Equity Research

    Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

    Here's How Mednax (MD) Can Gain By Adopting the Pediatrix Brand

    by Zacks Equity Research

    Mednax (MD) bringing some of its operations under the Pediatrix brand is expected to collectively promote its wide range of healthcare services.

    Wall Street Analysts Think Acadia Healthcare (ACHC) Could Surge 27%: Read This Before Placing a Bet

    by Zacks Equity Research

    The average of price targets set by Wall Street analysts indicates a potential upside of 27.3% in Acadia Healthcare (ACHC). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.

    Acadia Healthcare (ACHC) Q4 Earnings Miss on High Operating Costs

    by Zacks Equity Research

    Acadia Healthcare (ACHC) anticipates earnings per share within 62-66 cents for the March quarter of 2022.